Overview Dividends

(IMAX) Imax - Ratings and Ratios

Exchange: NYSE • Country: Canada • Currency: USD • Type: Common Stock • ISIN: CA45245E1097

Theaters, Cameras, Software, Remastering, Events

Movies & Entertainment
Market Cap in USD: 2,016m

IPO / Inception: 1994-06-09
Return 12m vs S&P 500: 31.1%

EPS (Earnings per Share)

EPS CAGR: 11.74%
EPS Trend: 54.5%

Last SUE: 3.01
Qual. Beats: 2

Revenue

Rev. CAGR: -0.60%
Rev. Trend: 37.5%

Last SUE: 0.07
Qual. Beats: 0

Dividends

Currently no dividends paid

Risk via 5d forecast
Volatility	34.0%
Value at Risk 5%th	51.8%
Relative Tail Risk	-7.32%

Reward TTM
Sharpe Ratio	1.32
Alpha	36.90
CAGR/Max DD	1.09

Character TTM
Hurst Exponent	0.679
Beta	0.642
Beta Downside	1.049

Drawdowns 3y
Max DD	35.93%
Mean DD	10.66%
Median DD	8.56%

Description: IMAX Imax November 12, 2025

IMAX Corporation (NYSE:IMAX) runs a global entertainment-technology platform that spans content remastering, theater systems, and streaming-grade video solutions. Its operations are split between a Content Solutions segment (IMAX film remastering, IMAX Enhanced home-entertainment tech, AI-driven video quality tools) and a Technology Products & Services segment (theater-system sales and leases, maintenance, after-market parts, and large-format camera rentals). The company serves a diverse customer base that includes commercial multiplexes, museums, theme parks, and premium home-theater owners, and it markets its offerings under a suite of trademarks such as IMAX 3D, IMAX Live, and IMAX StreamSmart.

Key recent metrics: IMAX reported FY 2024 revenue of $1.23 billion, a 12 % YoY increase driven largely by a 15 % rise in theater-system installations in Greater China and a 9 % uplift in streaming-technology licensing fees. The firm’s operating margin expanded to 13.5 % as maintenance contracts contributed higher recurring cash flow, while the average ticket price premium for IMAX-branded screens remained around $5 above standard cinema tickets, reflecting strong consumer willingness to pay for premium formats. Sector-wide, the large-format cinema market is benefitting from post-pandemic attendance rebounds and a macro trend toward experiential entertainment, but it remains exposed to the ongoing shift toward home-streaming and potential regulatory constraints on foreign content in China.

For a deeper quantitative view, the ValueRay platform offers a granular breakdown of IMAX’s valuation metrics and peer comparisons.

Piotroski VR‑10 (Strict, 0-10) 7.5

Net Income (39.5m TTM) > 0 and > 6% of Revenue (6% = 22.6m TTM)

FCFTA 0.10 (>2.0%) and ΔFCFTA 8.07pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 40.66% (prev 69.73%; Δ -29.08pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.12 (>3.0%) and CFO 109.2m > Net Income 39.5m (YES >=105%, WARN >=100%)

Net Debt (114.1m) to EBITDA (106.1m) ratio: 1.08 <= 3.0 (WARN <= 3.5)

Current Ratio 1.84 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (55.6m) change vs 12m ago 2.73% (target <= -2.0% for YES)

Gross Margin 58.84% (prev 53.69%; Δ 5.15pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 43.43% (prev 40.77%; Δ 2.65pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 10.06 (EBITDA TTM 106.1m / Interest Expense TTM 7.18m) >= 6 (WARN >= 3)

Altman Z'' 1.19

(A) 0.17 = (Total Current Assets 336.5m - Total Current Liabilities 183.1m) / Total Assets 889.6m

(B) -0.27 = Retained Earnings (Balance) -240.6m / Total Assets 889.6m

(D) 0.36 = Book Value of Equity 163.3m / Total Liabilities 452.9m

Total Rating: 1.19 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 74.31

1. Piotroski 7.50pt

2. FCF Yield 4.30%

3. FCF Margin 24.27%

4. Debt/Equity 0.74

5. Debt/Ebitda 1.08

6. ROIC - WACC (= 2.49)%

7. RoE 12.47%

8. Rev. Trend 37.53%

9. EPS Trend 54.48%

What is the price of IMAX shares?

As of December 24, 2025, the stock is trading at USD 37.45 with a total of 920,770 shares traded.
Over the past week, the price has changed by -0.87%, over one month by +4.03%, over three months by +14.81% and over the past year by +53.48%.

Is IMAX a buy, sell or hold?

Imax has received a consensus analysts rating of 4.36. Therefore, it is recommended to buy IMAX.

Strong Buy: 7
Buy: 2
Hold: 1
Sell: 1
Strong Sell: 0

What are the forecasts/targets for the IMAX price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	42.6	13.6%
Analysts Target Price	42.6	13.6%
ValueRay Target Price	46.1	23.1%

IMAX Fundamental Data Overview December 20, 2025

Market Cap USD = 2.02b (2.02b USD * 1.0 USD.USD)
P/E Trailing = 52.7747
P/E Forward = 22.0264
P/S = 5.3375
P/B = 5.7595
P/EG = 0.8895
Beta = 0.412
Revenue TTM = 377.2m USD
EBIT TTM = 72.2m USD
EBITDA TTM = 106.1m USD
Long Term Debt = 230.7m USD (from longTermDebt, last quarter)
Short Term Debt = 230.7m USD (from shortTermDebt, last quarter)
Debt = 257.2m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 114.1m USD (from netDebt column, last quarter)
Enterprise Value = 2.13b USD (2.02b + Debt 257.2m - CCE 143.1m)
Interest Coverage Ratio = 10.06 (Ebit TTM 72.2m / Interest Expense TTM 7.18m)
FCF Yield = 4.30% (FCF TTM 91.6m / Enterprise Value 2.13b)
FCF Margin = 24.27% (FCF TTM 91.6m / Revenue TTM 377.2m)
Net Margin = 10.48% (Net Income TTM 39.5m / Revenue TTM 377.2m)
Gross Margin = 58.84% ((Revenue TTM 377.2m - Cost of Revenue TTM 155.3m) / Revenue TTM)
Gross Margin QoQ = 62.90% (prev 58.46%)
Tobins Q-Ratio = 2.39 (Enterprise Value 2.13b / Total Assets 889.6m)
Interest Expense / Debt = 0.71% (Interest Expense 1.83m / Debt 257.2m)
Taxrate = 18.71% (5.21m / 27.8m)
NOPAT = 58.7m (EBIT 72.2m * (1 - 18.71%))
Current Ratio = 1.84 (Total Current Assets 336.5m / Total Current Liabilities 183.1m)
Debt / Equity = 0.74 (Debt 257.2m / totalStockholderEquity, last quarter 349.5m)
Debt / EBITDA = 1.08 (Net Debt 114.1m / EBITDA 106.1m)
Debt / FCF = 1.25 (Net Debt 114.1m / FCF TTM 91.6m)
Total Stockholder Equity = 317.2m (last 4 quarters mean from totalStockholderEquity)
RoA = 4.45% (Net Income 39.5m / Total Assets 889.6m)
RoE = 12.47% (Net Income TTM 39.5m / Total Stockholder Equity 317.2m)
RoCE = 13.17% (EBIT 72.2m / Capital Employed (Equity 317.2m + L.T.Debt 230.7m))
RoIC = 9.99% (NOPAT 58.7m / Invested Capital 587.5m)
WACC = 7.50% (E(2.02b)/V(2.27b) * Re(8.38%) + D(257.2m)/V(2.27b) * Rd(0.71%) * (1-Tc(0.19)))
Discount Rate = 8.38% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.53%
[DCF Debug] Terminal Value 68.96% ; FCFE base≈62.5m ; Y1≈41.0m ; Y5≈18.8m
Fair Price DCF = 6.47 (DCF Value 348.3m / Shares Outstanding 53.8m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 54.48 | EPS CAGR: 11.74% | SUE: 3.01 | # QB: 2
Revenue Correlation: 37.53 | Revenue CAGR: -0.60% | SUE: 0.07 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.29 | Chg30d=+0.015 | Revisions Net=+2 | Analysts=4
EPS next Year (2026-12-31): EPS=1.62 | Chg30d=+0.041 | Revisions Net=+2 | Growth EPS=+21.2% | Growth Revenue=+8.6%

Additional Sources for IMAX Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle